Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Jan-24 8:37 PM View:  | Gallagher Carol Giltner Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 14,363 | -- | -- | (100%) 14.36K to 0 | |
| 23-Jan-24 8:37 PM View: | Johnson Craig A Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 17,273 | -- | -- | (100%) 17.27K to 0 | |
| 23-Jan-24 8:37 PM View: | Hickey Benjamin EVP, Chief Commercial Officer | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 117,028 | -- | -- | (100%) 117.03K to 0 | |
| 25-Jan-24 4:32 PM View: | Boxer Capital, LLC | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 287,866 | -- | -- | (4%) 6.86M to 6.57M | |
| 23-Jan-24 8:38 PM View: | Davis Aaron I. Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 54,325 | -- | -- | (100%) 54.33K to 0 | |
| 23-Jan-24 8:37 PM View: | Martinez Maria E Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 17,273 | -- | -- | (100%) 17.27K to 0 | |
| 23-Jan-24 8:37 PM View: | Christensen Jamie EVP & Chief Scientific Officer | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 154,996 | -- | -- | (100%) 155.0K to 0 | |
| 23-Jan-24 8:38 PM View: | Sharp Shalini Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 16,222 | -- | -- | (100%) 16.22K to 0 | |
| 25-Jan-24 4:32 PM View: | Boxer Capital, LLC | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 3,201,440 | -- | -- | (49%) 6.57M to 3.37M | |
| 23-Jan-24 8:37 PM View: | Hasnain Faheem Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 24,752 | -- | -- | (100%) 24.75K to 0 | |
| 23-Jan-24 8:37 PM View: | Baum Charles M Founder, President, and CEO Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 237,871 | -- | -- | (100%) 237.87K to 0 | |
| 23-Jan-24 8:37 PM View: | Carter Bruce L A Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 17,273 | -- | -- | (100%) 17.27K to 0 | |
| 23-Jan-24 8:37 PM View: | Sandler Alan B. Chief Medical Officer | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 79,865 | -- | -- | (100%) 79.86K to 0 | |
| 23-Jan-24 8:38 PM View: | Cherrington Julie M Director | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 11,252 | -- | -- | (100%) 11.25K to 0 | |
| 23-Jan-24 8:37 PM View: | Moriarty John B Chief Legal Officer | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 72,335 | -- | -- | (100%) 72.33K to 0 | |
| 25-Jan-24 4:32 PM View: | Boxer Capital, LLC | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 3,370,240 | -- | -- | (100%) 3.37M to 0 | |
| 23-Jan-24 8:37 PM View: | Ondrey Aaron Chief Financial Officer | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 39,461 | -- | -- | (100%) 39.46K to 0 | |
| 18-Jan-24 4:45 PM View: | Hickey Benjamin EVP, Chief Commercial Officer | Mirati Therapeutics, Inc. (MRTX) | 16-Jan-24 | Sale | 1,597 | $59.02 | $94,254.90 | (1%) 118.63K to 117.03K | |
| 18-Jan-24 4:38 PM View: | Christensen Jamie EVP & Chief Scientific Officer | Mirati Therapeutics, Inc. (MRTX) | 16-Jan-24 | Sale | 1,597 | $59.02 | $94,254.90 | (1%) 157.52K to 155.93K | |
| 09-Jan-24 5:54 PM View: | Hickey Benjamin EVP, Chief Commercial Officer | Mirati Therapeutics, Inc. (MRTX) | 08-Jan-24 | Sale | 2,090 | $58.92 | $123,143.00 | (2%) 120.72K to 118.63K | |
| 05-Jan-24 5:34 PM View: | Christensen Jamie EVP & Chief Scientific Officer | Mirati Therapeutics, Inc. (MRTX) | 04-Jan-24 | Sale | 1,531 | $58.81 | $90,038.10 | (< 1%) 158.67K to 157.13K | |
| 03-Jan-24 6:32 PM View: | Martinez Maria E Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 65% 10.46K to 17.27K | |
| 03-Jan-24 6:05 PM View: | Christensen Jamie EVP & Chief Scientific Officer | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 17,021 | $58.75 | $999,984.00 | 12% 141.65K to 158.67K | |
| 03-Jan-24 6:24 PM View: | Sharp Shalini Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 72% 9.41K to 16.22K | |
| 03-Jan-24 6:18 PM View: | Hasnain Faheem Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 9,702 | $58.75 | $569,992.00 | 64% 15.05K to 24.75K | |
| 03-Jan-24 6:16 PM View: | Carter Bruce L A Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 65% 10.46K to 17.27K | |
| 03-Jan-24 6:01 PM View: | Sandler Alan B. Chief Medical Officer | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 17,021 | $58.75 | $999,984.00 | 27% 62.3K to 79.32K | |
| 03-Jan-24 6:22 PM View: | Cherrington Julie M Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 153% 4.44K to 11.25K | |
| 03-Jan-24 5:52 PM View: | Baum Charles M Interim CEO Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 20,425 | $58.75 | $1,199,970.00 | 9% 227.28K to 247.7K | |
| 03-Jan-24 5:55 PM View: | Ondrey Aaron CFO | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 17,021 | $58.75 | $999,984.00 | 76% 22.44K to 39.46K | |
| 03-Jan-24 6:27 PM View: | Gallagher Carol Giltner Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 90% 7.55K to 14.36K | |
| 03-Jan-24 6:37 PM View: | Johnson Craig A Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 65% 10.46K to 17.27K | |
| 03-Jan-24 6:13 PM View: | Hickey Benjamin EVP, Chief Commercial Officer | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 17,021 | $58.75 | $999,984.00 | 16% 103.69K to 120.72K | |
| 03-Jan-24 8:50 PM View: | Davis Aaron I. Director | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 14% 47.52K to 54.33K | |
| 19-Dec-23 4:59 PM View: | Christensen Jamie EVP & Chief Scientific Officer | Mirati Therapeutics, Inc. (MRTX) | 18-Dec-23 | Sale | 2,387 | $57.50 | $137,252.00 | (2%) 144.03K to 141.65K | |
| 14-Dec-23 5:05 PM View: | Hickey Benjamin EVP, Chief Commercial Officer | Mirati Therapeutics, Inc. (MRTX) | 13-Dec-23 | Sale | 2,220 | $56.67 | $125,807.00 | (2%) 105.91K to 103.69K | |
| 12-Sep-23 5:30 PM View: | Ondrey Aaron Interim CFO | Mirati Therapeutics, Inc. (MRTX) | 08-Sep-23 | Grant | 8,412 | $35.66 | $299,972.00 | 60% 14.03K to 22.44K | |
| 12-Sep-23 5:41 PM View: | Christensen Jamie EVP & Chief Scientific Officer | Mirati Therapeutics, Inc. (MRTX) | 08-Sep-23 | Sale | 2,388 | $35.63 | $85,084.40 | (2%) 146.42K to 144.03K | |
| 15-Aug-23 9:38 PM View: | Boxer Capital, LLC | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Purchase | 1,201,440 | $27.80 | $33,400,000.00 | 22% 5.47M to 6.67M | |
| 15-Aug-23 9:39 PM View: | Boxer Capital, LLC | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Private Purchase Duplicate | 57,533 | $27.80 | $1,599,420.00 | 1% 5.41M to 5.47M | |
| 15-Aug-23 9:38 PM View: | Boxer Capital, LLC | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Private Purchase | 57,533 | $27.80 | $1,599,420.00 | 1% 5.41M to 5.47M | |
| 15-Aug-23 9:39 PM View: | Boxer Capital, LLC | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Purchase Duplicate | 1,201,440 | $27.80 | $33,400,000.00 | 22% 5.47M to 6.67M | |
| 14-Aug-23 4:41 PM View: | Hasnain Faheem Director | Mirati Therapeutics, Inc. (MRTX) | 11-Aug-23 | Private Purchase | 10,791 | $27.80 | $299,990.00 | 72% 15.05K to 25.84K | |
| 10-Aug-23 4:24 PM View: | Baum Charles M Interim CEO Director | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 54,054 | $37.00 | $2,000,000.00 | 31% 173.22K to 227.28K | |
| 10-Aug-23 4:23 PM View: | Hickey Benjamin EVP, Chief Commercial Officer | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 27% 83.62K to 105.91K | |
| 10-Aug-23 4:22 PM View: | Moriarty John B Chief Legal Officer | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 45% 49.36K to 71.66K | |
| 10-Aug-23 4:26 PM View: | Stelzer Laurie Chief Financial Officer | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 28% 80.02K to 102.31K | |
| 10-Aug-23 4:19 PM View: | Sandler Alan B. Chief Medical Officer | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 56% 40.0K to 62.3K | |
| 10-Aug-23 4:21 PM View: | Christensen Jamie EVP & Chief Scientific Officer | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 18% 124.12K to 146.42K | |
| 23-Jun-23 5:18 PM View: | Gallagher Carol Giltner Director | Mirati Therapeutics, Inc. (MRTX) | 22-Jun-23 | Grant | 7,555 | -- | -- | 100% 0 to 7.55K |
